Stock listing
HVO Stock Price, News, Filings & Events — Hvivo Plc
Selected listing: HVO · LSE · GBX · GB
This page tracks Hvivo Plc's HVO:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HVO:LSE. HVO:LSE is the stock-level entry point for investors researching Hvivo Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Hvivo Plc is a public company listed on the UK market under the ticker HVO, with a market capitalization of approximately £61.4 million. The company specializes in the development and commercialization of innovative solutions for infectious diseases. Hvivo focuses on advancing its proprietary technologies and conducting clinical trials to support its product pipeline.

- Ticker
- HVO:LSE
- Asset type
- Stock
- Market cap
- $61.9M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- LSE
- Currency
- GBX
Hvivo Plc HVO:LSE stock context
This page tracks Hvivo Plc's HVO:LSE listing on LSE in GBX for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HVO:LSE. HVO:LSE is the stock-level entry point for investors researching Hvivo Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Hvivo Plc is a public company listed on the UK market under the ticker HVO, with a market capitalization of approximately £61.4 million. The company specializes in the development and commercialization of innovative solutions for infectious diseases. Hvivo focuses on advancing its proprietary technologies and conducting clinical trials to support its product pipeline.
Latest news from Hvivo Plc
Research Hvivo Plc
Hvivo Plc investor report
Review AI stock analysis and investor report context for HVO:LSE.
Hvivo Plc company profile
View the public company page for Hvivo Plc on 6ix.
Hvivo Plc news
Read company news and market updates connected to Hvivo Plc.
Hvivo Plc investor events
Find investor webinars, events, and replay context for Hvivo Plc.
Alternate listings
CRO:GETTEX
DE · EUR
Alternate listing for Hvivo Plc; the primary context on this page is HVO:LSE.
CRO:SWB
DE · EUR
Alternate listing for Hvivo Plc; the primary context on this page is HVO:LSE.
CRO:FWB
DE · EUR
Alternate listing for Hvivo Plc; the primary context on this page is HVO:LSE.
A1KAME:LSX
DE · EUR
Alternate listing for Hvivo Plc; the primary context on this page is HVO:LSE.
A1KAME:LS
DE · EUR
Alternate listing for Hvivo Plc; the primary context on this page is HVO:LSE.
CRO:DUS
DE · EUR
Alternate listing for Hvivo Plc; the primary context on this page is HVO:LSE.
HVO.GB:AQUIS
GB · GBX
Alternate listing for Hvivo Plc; the primary context on this page is HVO:LSE.
CRO:MUN
DE · EUR
Alternate listing for Hvivo Plc; the primary context on this page is HVO:LSE.
OPORF:OTC
US · USD
Alternate listing for Hvivo Plc; the primary context on this page is HVO:LSE.